Browsing by Subject "sibutramine"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
Item Use of sibutramine (Meridia) in obese patients with Type 2 diabetes is associated with statistically significant weight loss and a decreased hemoglobin A1c(2008-10-16) Sandvig, LisaAbstract: In a meta-analysis of 8 randomized controlled trials including obese patients with Type 2 diabetes, the addition of sibutramine to standard diabetes therapy resulted in a significant decrease in body weight and hemoglobin A1c.